Ebarola, Bonifacia R.
HRN: 08-99-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
CEFUROXIME 500MG (TAB)
08/03/2022
08/10/2022
ORAL
500mg
BID
SP Explore Lap
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes